GLPwatch
Trials (2036)
Page 6 of 34.
- Semaglutide Treatment for Hyperglycaemia After Renal Transplantation
- Natriuretic Effect of GLP-1in Healthy Non Obese Subjects
- Title: Therapeutic Targets in African-American Youth With Type 2 Diabetes
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- Effect of Weekly GLP1 Agonist Treatment in "Double Diabetes"
- Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by Metformin
- Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
- GLP1R Polymorphisms and Response to GLP1
- The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
- Reward Mechanisms in Obesity
- Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
- Impact of Liraglutide 3.0 on Body Fat Distribution
- A Research Study Looking at the Comparability of 2 Different Forms of Oral Semaglutide in Healthy People
- A Study of IBI362 9 mg in Chinese Adults With Obesity
- 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
- A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss
- Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
- A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
- A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
- The Effects of Liraglutide on Sudomotor Function and Inflammation in Type 2 Diabetes
- A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
- A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
- Incretin-based Drugs and Acute Pancreatitis
- A Study of Retatrutide (LY3437943) in Participants Without Type 2 Diabetes Who Have Obesity or Overweight
- Study of Tirzepatide in Healthy Participants
- A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Finland, as Part of Local Clinical Practice
- Metabolic Defects in Prediabetic Kuwaiti Arabs and Indians
- Study of Immune Cells in Obese Patients With Type 2 Diabetes Mellitus Treated With Liraglutide
- A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes
- Study of RO6807952 in Patients With Diabetes Mellitus Type 2
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
- Semaglutide in Auto-HSCT
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- A Study to Compare the Effect of Giving Dulaglutide Using an Auto-injector Versus a Manual Syringe
- A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes
- Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
- A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)
- Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects.
- Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
- CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- A Trial to Determine the Efficacy and Safety of Presendin in IIH
- Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
- Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Bioenergetic Alterations After Exenatide Administration
- A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use
- CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy
- Effect and Safety of Liraglutide 3.0 mg in Subjects With Overweight or Obesity and Type 2 Diabetes Mellitus Treated With Basal Insulin
- A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
- Ultrasound Assessment of the Adventitia, Extra-media (EMT) and Veia Jugularis Interna Thickness
- Research Study to Compare Semaglutide Tablets With Empagliflozin or Metformin Tablets in People With Type 2 Diabetes
- Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)